Ticker LaunchDirect listing · TTRX
Turn Therapeutics Inc.
Formerly Global Health Solutions, Inc
Turn Therapeutics Inc. (TTRX) went public through a direct listing on Nasdaq Global Market on Oct 8, 2025, with a reference price of $11.65. Davis Polk and Nelson Mullins advised the company.
Turn Therapeutics Inc. is a pharmaceutical and medical device development company built on a proprietary platform technology, PermaFusion, a patented mixing process that suspends water-soluble active ingredients in oil-based carriers without emulsifiers.
- Status
- Direct listing
- Ticker
- TTRX
- Exchange
- Nasdaq Global Market
- Listed
- Oct 8, 2025
- Price
- $11.65
- First filed
- Sep 2, 2025
- Company counsel
- Davis Polk and Nelson Mullins
- Sector
- Biotech & pharma
- Country / state
- CA
More on this listing for subscribers
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Sep 2, 2025
- Latest amendment Sep 24, 2025
- Final prospectus (424B4) Oct 8, 2025
- All filings on EDGAR CIK 2023016
Other Biotech & pharma direct listings in 2025
- Functional Brands Inc.MEHA · Nov 6, 2025
- Neonc Technologies Holdings, Inc.NTHI · Mar 25, 2025